Carcinoma: all 6,719 studies

Page 56 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.

• Developing an In-vitro Diagnostic Risk-Stratification Test for Oral CancerStatus unknownNCT01587573
• Intensity-Modulated or Proton Radiation Therapy for Sinonasal MalignancyActive, not recruitingNCT01586767Not applicable
• Stereotactic Boost for Oropharyngeal Squamous Cell CarcinomaWithdrawnNCT01586182Phase 1/2
• Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell CarcinomaCompletedNCT01585974
• Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell CarcinomaTerminatedNCT01582672Phase 3
• Pazopanib in Second-line Therapy in Renal Cell CarcinomaStatus unknownNCT01577784Phase 2
• A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma PatientsCompletedNCT01576380Phase 2
• Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal CarcinomatosisCompletedNCT01575730Phase 2
• The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant ListStatus unknownNCT01575717Not applicable
• Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive DiagnosisCompletedNCT01575574Phase 4
• Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular CarcinomaStatus unknownNCT01570166Not applicable
• Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan CriteriaStatus unknownNCT01570075Phase 4
• Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility StudyTerminatedNCT01569321Not applicable
• Temsirolimus as Second-line Therapy in HCCStatus unknownNCT01567930Phase 2
• Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5CompletedNCT01566747Phase 2
• Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast MediaStatus unknownNCT01563484
• Study of Metformin With Simvastatin for Men With Prostate CarcinomaWithdrawnNCT01561482Phase 2
• Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the LungCompletedNCT01561456Phase 2
• Representation of the Body for Patients With CancerCompletedNCT01560533Not applicable
• Nexavar Dosing in Renal Cancer Patients in "Real-life" SettingCompletedNCT01557127
• Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaStatus unknownNCT01556815Phase 2
• Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical CarcinomaCompletedNCT01554410Phase 1
• Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT01548482Phase 1
• Lenalidomide as Second-line Treatment for Advanced Hepatocellular CarcinomaCompletedNCT01545804Phase 2
• CAre of Patients With PArenteral Nutrition At HomeCompletedNCT01545063
• TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell CarcinomaCompletedNCT01542931Phase 2/3
• Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E HistologyCompletedNCT01540695
• Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)CompletedNCT01540461Phase 1
• Combined Anticancer Treatment of Advanced Colon CancerTerminatedNCT01540344Phase 2
• Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal CarcinomaCompletedNCT01540136Phase 3
• Sorafenib in Hepatocellular Carcinoma Clinical Practice in ItalyCompletedNCT01539681
• Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian CancerCompletedNCT01538498
• Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and NeckCompletedNCT01538381Phase 2
• A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 ExpressionCompletedNCT01536743Phase 2
• Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal CarcinomaStatus unknownNCT01536223Phase 3
• Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian CancerTerminatedNCT01535157Phase 1/2
• Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal CarcinomaCompletedNCT01534585Phase 1/2
• Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 DissectionStatus unknownNCT01534546Phase 3
• S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT01533324Phase 2
• Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal CarcinomaCompletedNCT01528618Phase 3
• Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01528163Phase 2
• Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerTerminatedNCT01528137Phase 1
• Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01527877Phase 2
• Videoscopic Versus Open Inguinal Lymphadenectomy for CancerCompletedNCT01526486Not applicable
• A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney CancerCompletedNCT01525017Phase 1
• Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal CarcinomatosisCompletedNCT01524094Phase 3
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
• First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell CarcinomaCompletedNCT01521715Phase 4
• Recurrence of Hepatocellular CarcinomaCompletedNCT01520779
• Procalcitonin in Hepatocellular CarcinomaCompletedNCT01518829
• Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical CarcinomaCompletedNCT01514526Phase 2
• Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell CarcinomaCompletedNCT01513187Phase 1/2
• RCT on Adjuvant TACE After Hepatectomy for HCCCompletedNCT01512407Not applicable
• Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell CarcinomaCompletedNCT01510119Phase 1/2
• Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell CarcinomaCompletedNCT01508364
• IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01507467Phase 3
• A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular CarcinomaCompletedNCT01507168Phase 2
• Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular CarcinomaCompletedNCT01507064Phase 2
• Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular CarcinomaCompletedNCT01506115Not applicable
• Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer SurvivorsCompletedNCT01504932Not applicable
• Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
• Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01504126Early Phase 1
• Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic LiverWithdrawnNCT01501240
• Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell CarcinomaCompletedNCT01500954
• Genome-wide Association StudyWithdrawnNCT01498757
• Microarray Analysis of microRNA Expression in Basal Cell CarcinomaCompletedNCT01498250
• AMG 172 First in Human Study in Patients With Kidney CancerCompletedNCT01497821Phase 1
• A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentStatus unknownNCT01497041Phase 2
• Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea PolyphenolsStatus unknownNCT01496521Phase 3
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerStatus unknownNCT01494415Phase 2
• Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing ChemotherapyWithdrawnNCT01492920Phase 3
• Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative TreatmentStatus unknownNCT01492127Not applicable
• Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage MethylaminolevulinateStatus unknownNCT01491711Phase 4
• Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT01491139Phase 1
• Pemetrexed and Cisplatin in Advanced Urothelial CarcinomaCompletedNCT01490437Phase 2
• Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular CarcinomaCompletedNCT01490203
• Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT01489566Phase 3
• Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular CarcinomaWithdrawnNCT01489410Not applicable
• EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01489371Phase 1
• Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial CarcinomaStatus unknownNCT01487915Phase 2
• Lipid Metabolic Status in Thyroid CarcinomaCompletedNCT01487057
• mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the EsophagusStatus unknownNCT01486992Phase 2
• A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01484847Not applicable
• Axitinib as Maintenance Treatment in Patients With Metastatic CRCTerminatedNCT01483638Phase 2
• A Rollover Protocol for Subjects Previously Treated With AGS-003TerminatedNCT01482949Phase 2
• Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell CarcinomaCompletedNCT01482520
• SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular CarcinomaCompletedNCT01482442Phase 3
• New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)CompletedNCT01482104Not applicable
• Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell CarcinomaStatus unknownNCT01481870Phase 3
• Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma PatientsCompletedNCT01481805
• A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian CarcinomaCompletedNCT01481701Phase 2
• Sorafenib VS TACE in HCC Patients With Portal Vein InvasionTerminatedNCT01480817Phase 2
• A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01479504Phase 3
• A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
• Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell CarcinomaCompletedNCT01474642Phase 2
• Hepatocellular Carcinoma Registry for Turkey (3K Trial)CompletedNCT01473121
• Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line TreatmentNo longer availableNCT01473043
• Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT01472419
• A Trial of JX-594 in Refractory Colorectal CarcinomaCompletedNCT01469611Phase 1
• Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell CancerCompletedNCT01469598Phase 2

← Carcinoma overview